Florida Cannabis Dispensaries Reach 757: What Industry Sources Are Seeing on the Ground

Florida’s medical cannabis market continued its steady expansion this spring, with new state data showing more than 6.4 billion milligrams of THC sold so far in 2026 and 757 licensed dispensaries operating across the state. The figures come from the April 17 update published by the Florida Office of Medical Marijuana Use, which tracks weekly sales of smokable flower, THC products, CBD products, and the number of active dispensing locations.

The Marijuana Herald highlighted the milestone, noting that Florida’s patient base remains one of the largest in the country and that retail access continues to grow as established operators add new storefronts. The OMMU update shows that smokable flower sales remain a major driver of volume, while THC products across other categories continue to post strong weekly totals. The state’s vertically integrated structure means each licensed operator controls cultivation, processing, and retail, keeping the number of active companies relatively small even as the total number of dispensaries climbs.

What the Latest Data Says About Market Conditions

To better understand what the latest data signals for the health and direction of the market, IgniteIt connected with two industry leaders who have been closely following Florida’s regulatory and commercial landscape.

Jasmine Johnson, founder and CEO of GŪD Essence, said the numbers confirm the strength of patient demand but do not fully capture market accessibility.

“The latest data reinforces what operators have known for some time: demand in Florida is not the issue. Surpassing 6.4 billion milligrams of THC sold reflects a highly active and mature consumer base,” Johnson said in a written interview. “What it also highlights, however, is the growing gap between market demand and market access. The structure remains extremely capital‑intensive and vertically integrated, which limits participation and slows innovation.”

Johnson said her company plans to continue investing in Florida, but with a focus on sustainable growth rather than rapid expansion. She pointed to the cost of entry, regulatory timelines, and the need for operational discipline as key considerations.

“Florida is a strong market, but it requires thoughtful capital deployment given the regulatory timelines and cost of entry,” she said.

A Stable Market Preparing for New Entrants

Attorney Paula Savchenko, founding partner at Cannacore Group, said the OMMU data reinforces Florida’s position as one of the most stable medical cannabis markets in the country.

“The latest data from the Florida Office of Medical Marijuana Use continues to confirm that Florida remains one of the strongest and most stable medical cannabis markets in the country,” Savchenko told IgniteIt in a written interview. “The scale of THC sales and the continued growth in dispensary locations reflect both sustained patient demand and a mature, vertically integrated system that has proven highly durable.”

Savchenko noted that the market’s structure has historically favored well‑capitalized operators capable of building full vertical operations. That dynamic is expected to shift later this year as new licenses move toward approval.

“There are 22 additional licenses expected to come online later this year, which will introduce new operators and increase competition,” she said. She added that an administrative law judge is expected to issue a recommended order in May, followed by a 90‑day window for the Department of Health to issue a final order. That timeline places final approvals in the July to August range.

What Comes Next for Operators and Patients

Both experts emphasized that strong sales figures do not necessarily reflect a fully healthy or equitable market. Operators continue to navigate high overhead, regulatory delays, and evolving compliance requirements. Johnson said the next phase of Florida’s market will be shaped by efficiency, product quality, and consumer trust rather than sheer scale.

“Many operators are carrying significant overhead while navigating regulatory delays and evolving compliance requirements,” she said. “As more operators come online, differentiation will matter, and we’re starting to see a shift toward more refined, consumer‑focused brands.”

Savchenko said Florida’s structure has created a uniquely valuable market, but one that is still evolving as new entrants prepare to join.

“What makes Florida unique is that it’s not just a large market, it’s a structurally valuable one,” she said. “The vertical integration requirement has created high barriers to entry, which has stabilized the market and driven significant investment into infrastructure.”

With patient demand holding strong, dispensary counts rising, and new licenses on the horizon, Florida’s medical cannabis market is entering a new period of competition and recalibration. The latest OMMU data shows a program with significant momentum, but also one where access, cost, and regulatory complexity continue to shape the landscape for operators and patients alike.